Floatz logo

trx103

Crohns Disease

Tr1X, Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Crohns Disease cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
University of Saskatchewan
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cedars-Sinai Medical Center
Phase 4BB
Prucalopride
University of British Columbia
Phase 4BB
Hextend
Corewell Health West
Phase 3BB

View all 20 →

Same molecule, other indications

trx103 is also rated in:

disease related to hematopoietic stem cell transplantDormant
CC
Indicative ·
43 / 100
View asset →
graft versus host diseaseDormant
CC
Indicative ·
43 / 100
View asset →
B-cell adult acute lymphocytic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →